Cramer advised holding Eli Lilly stock long term and buying Astera Labs stock unconditionally.

1 report, 1 independent Updated Jul 29

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Cramer Eli Lilly and Company Astera Labs

Keep exploring

Part of

Eli Lilly and Company's performance is noted as a driver of investment opportunities in financial markets. All 2 developments

The entities involved

Cramer
- Cramer advises viewers to buy GEV shares, noting that the company benefits from Trump tariffs and onshoring.Sun 01:18
Eli Lilly and Company
American pharmaceutical company
- ExxonMobil, Berkshire Hathaway, and Eli Lilly are top holdings in the Avantis ETF.Mon 17:18
- The FDA approved Olumiant for pediatric indications on September 1, 2026.Mon 05:59
Astera Labs
semiconductor company
- MarketBeat lists several companies, including Nokia, IBM, Astera Labs, Marvell Technology, and Vertiv, as infrastructure stocks to watch today.Mon 01:04
- Astera Labs, Credo, and Marvell Technology are noted as pure-play rivals leading the AI infrastructure market.Sun 13:42

Related events

Soutrik Banerjee is currently employed as a consultant at Eli Lilly and Company.Sep 11
Astera Labs stock traded on the electronic Nasdaq exchange on August 19, 2026.Aug 20

Coverage

Newest first; wire copies grouped

Jul 29cnbc.com